Acturum Life Science AB has a total of 16 patent applications. Its first patent ever was published in 2011. It filed its patents most often in WIPO (World Intellectual Property Organization), China and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are THERAVANCE, ORION CORP and BARBOSA JOSEPH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | China | 5 | |
#3 | United States | 3 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Paulsen Kim | 10 |
#2 | Yngve Ulrika | 9 |
#3 | Besidski Yevgeni | 9 |
#4 | Malmborg Jonas | 9 |
#5 | Linde Christian | 6 |
#6 | Hettman Andreas | 4 |
#7 | Linde Christian Erik | 4 |
#8 | Nord Johan | 4 |
#9 | Macsari Istvan | 4 |
#10 | Bylund Johan | 4 |
Publication | Filing date | Title |
---|---|---|
WO2016085392A1 | Bis(sulfonamide) derivatives and their use as mpges inhibitors | |
WO2016085391A1 | Bis(sulfonamide) derivatives and their use as mpges inhibitors | |
WO2014195321A1 | Triazole compounds and their use as gamma secretase modulators | |
CN105263922A | Triazole compounds and their use as gamma secretase modulators | |
CN105263923A | Pyrimidine compounds and their use as gamma secretase modulators | |
WO2014184248A2 | Trpa1 antagonist compounds | |
WO2014184235A1 | Benzamide trpa1 antagonists |